The Blue Jet Healthcare initial public offering (IPO) auction was held from October 25, 2023, to October 27, 2023. On November 1, 2023 at https://linkintime.co.in/mipo/ipoallotment.html, the Blue Jet Healthcare IPO Allotment Status is anticipated to be completed. On November 1, 2023, refunds will be initiated, and on November 3, 2023, shares will be credited to the demat account. The proposed listing date for the Blue Jet Healthcare IPO is November 6, 2023, and it will take place on the BSE and NSE.
Blue Jet Healthcare IPO Allotment Status
The book-built IPO of Blue Jet Healthcare is valued at Rs 840.27 crores. The whole purpose of the issuance is to sell 2.43 crore shares. Retail investors are required to invest a minimum of ₹14,878. In terms of sNII, the minimum lot size investment is 14 lots (602 shares), or ₹208,292, and in terms of bNII, it is 68 lots (2,924 shares), or ₹1,011,704.
- Tata Motors Tata Technologies IPO
- Plaza Wires IPO allocation status
- Manoj Vaibhav Gems IPO Allotment Status
- Zaggle Prepaid Ocean Services IPO Allotment Status
- SAMHI Hotels IPO Allotment Status
- Unihealth Consultancy IPO Allotment Status
- Pramara Promotions IPO
- Cash App Payment Pending
- Sassa Payment Status
- Tap to Check More Status Updates
J.P. Morgan India Private Limited, ICICI Securities Limited, and Kotak Mahindra Capital Company Limited are the book-running lead managers for the Blue Jet Healthcare IPO. The offering’s registrar is Link Intime India Private Ltd. Keep up with us if you want to know the daily price progress of the Blue Jet Healthcare IPO GMP along with the predicted listing price.
How to check the Blue Jet Healthcare IPO Allotment Status?
To check the Blue Jet Healthcare IPO Allotment Status, follow these steps:
- Visit the official website of the Registrar of the IPO at https://linkintime.co.in/mipo/ipoallotment.html/.
- Look for the IPO Allotment Status section.
- Enter your application number or PAN number.
- Submit the required details.
- The website will display your allotment status, indicating whether you have been allotted shares, the number of shares allotted, or if you haven’t been allotted any shares.
Blue Jet IPO GMP
The grey market premium (GMP) for Blue Jet Healthcare’s initial public offering was ₹34 today, the same as in the previous session. According to investorgain.com first thing in the morning, this information suggests that the price of Blue Jet Healthcare shares was trading at a premium of 34 on the grey market on Thursday. The temperature in the evening has fallen significantly, and it is now ₹2.
|IPO Open Date||October 25, 2023|
|IPO Close Date||October 27, 2023|
|Basis of Allotment||November 1, 2023|
|Initiation of Refunds||November 1, 2023|
|Credit of Shares to Demat||November 3, 2023|
|Listing Date||November 6, 2023|
The most recent GMP for the Blue Jet Healthcare IPO is 22, and it was most recently updated on October 29th, 2023 at 11:32 AM. Blue Jet Healthcare IPO’s expected listing price is 368 (cap price plus today’s GMP), based on the price band of 346.00. It is anticipated that each share will see a gain or loss of 6.36 percent. The GMP ranges from 0 to -95, with 0 being the lowest and -95 the highest.
Blue Jet Healthcare IPO Lot Size
Bids may be placed for multiples of 43 shares, with a minimum bid of 43. The lowest and maximum share and amount of investments made by HNIs and retail investors are shown below.
- Retail (Min): 43, ₹14,878
- Retail (Max): 559, ₹193,414
- S-HNI (Min): 602, ₹208,292
- S-HNI (Max): 2,881, ₹996,826
- B-HNI (Min): 2,924, ₹1,011,704
Blue Jet Healthcare IPO Reservation
24,285,160 shares are available in the Blue Jet Healthcare IPO. 4,857,032 (20.00%) went to QIB, 3,642,774 (15.00%) went to NII, 8,499,806 (35.00%) went to RII, and 7,285,548 (30.00%) of Anchor investors. A minimum of 43 shares will be awarded to 197,669 RIIs, while 2,017 sNII and 4,034 bNII will get a minimum of 602 shares. (If there is a large subscription).
Blue Jet IPO Review
With its produced goods, Blue Jet Healthcare has carved out a position for itself in the worldwide market and has established enduring relationships with FMCGs and major clients. It plans to increase its capacity and boost efficiency in the next few years.
The issue seems fully valued based on the annualized FY24 profits. Investors might put money aside for this long-term racehorse’s medium-to-long-term benefits, according to Chittorgarh contributing editor Dilip Davda.
Visit Rajneetpg2022 Homepage To Get Relevant Content.